Available: [8] Hudson Biotech, A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain Confirmed by MRI, clinicaltrials.gov, Clinical trial registration NCT07437547, Feb
mRNA expression studies at 1 and 24 hr, provided strongly elevated ( Egr1, Akt1, Kras, Src, Foxo, Srf, Vegfr2, Nos3, and Nos1 ) and decreased ( Nos2, Nfkb ) gene expression ( Mapk1 not activated), as a way how BPC 157 may act
Cellular NAD+ NAD+ Preservation By blocking NNMT, 5-Amino-1MQ preserves the cellular NAD+ pool, an essential cofactor for more than 500 metabolic reactions and for the activation of sirtuins
Note: Published safety data for TB-500 specifically is limitedmost evidence comes from Thymosin Beta-4 studies